Intuitive Surgical, Inc. (ISRG)
$
473.84
+2.69 (0.57%)
Key metrics
Financial statements
Free cash flow per share
4.8683
Market cap
169.9 Billion
Price to sales ratio
18.5741
Debt to equity
0
Current ratio
4.9787
Income quality
1.0952
Average inventory
1.5 Billion
ROE
0.1634
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The EBITDA ratio is 0.34 highlighting the company's operational efficiency. The company reported a substantial revenue of $8,352,100,000.00 reflecting its strong market presence. Additionally, it reported an income before tax of $2,673,800,000.00 showcasing its pre-tax profitability. The cost of revenue for the company is $2,717,900,000.00 showcasing its production and operational expenses. The financial data pertains to the fiscal year 2024. The company offers the da Vinci Surgical System, which facilitates complex surgeries through a minimally invasive approach, along with the Ion endoluminal system that broadens its commercial offerings into diagnostic procedures, enabling minimally invasive biopsies in the lung. Additionally, it provides a suite of stapling, energy, and core instrumentation for its surgical systems, along with progressive learning pathways to support the use of its technology. Intuitive Surgical also offers a range of services to its customers, including support, installation, repair, and maintenance, while its integrated digital capabilities provide unified and connected offerings that streamline hospital performance with program-enhancing insights. The stock is priced at $516.44 positioning it in the higher-end market. It is characterized by a high average trading volume of 1,913,050.00 indicating strong liquidity. With a large market capitalization of $169,860,267,840.00 the company is a dominant player in its field. It is a key player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape. Furthermore, Intuitive Surgical belongs to the Healthcare sector, driving innovation and growth. The focus on delivering enhanced surgical solutions combined with robust financial metrics underscores its prominent role in advancing minimally invasive healthcare solutions, reflecting both market stability and a commitment to quality in patient care.
Is Intuitive Surgical, Inc. (ISRG) a good investment?
Investing in Intuitive Surgical, Inc. (ISRG) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bullish outlook. Always conduct your own research before investing.
What is Intuitive Surgical, Inc. (ISRG)'s stock forecast?
Analysts predict Intuitive Surgical, Inc. stock to fluctuate between $425 (low) and $616 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Intuitive Surgical, Inc.'s market capitalization?
As of 2025-08-29, Intuitive Surgical, Inc.'s market cap is $169,860,267,840, based on 358,476,000 outstanding shares.
How does Intuitive Surgical, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Intuitive Surgical, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Intuitive Surgical, Inc. (ISRG) stock?
To buy Intuitive Surgical, Inc. (ISRG) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ISRG. Place an order (Market, Limit, etc.).
What is the best time to invest in Intuitive Surgical, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Intuitive Surgical, Inc. stock ever split?
Intuitive Surgical, Inc.'s last stock split was 3:1 on 2021-10-05.
How did Intuitive Surgical, Inc. perform in the last earnings report?
Revenue: $8,352,100,000 | EPS: $6.54 | Growth: 27.71%.
Where can I find Intuitive Surgical, Inc.'s investor relations reports?
Visit https://www.intuitive.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Intuitive Surgical, Inc.?
You can explore historical data from here
What is the all-time high and low for Intuitive Surgical, Inc. stock?
All-time high: $616 (2025-01-23) | All-time low: $180.07 (2022-10-13).
What are the key trends affecting Intuitive Surgical, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
fool.com
One of famed investor Warren Buffett's principles is to buy shares of wonderful companies at fair prices to hold for the long term. Let's try to use it to decide whether Intuitive Surgical (ISRG 1.22%), a medical device specialist, is worth investing in today.
zacks.com
Intuitive Surgical, Inc. (ISRG) closed at $476.16 in the latest trading session, marking a +1.34% move from the prior day.
zacks.com
Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.
fool.com
Investing styles tend to evolve as people age. Seniors who are already retired often look for steady, reliable, dividend-paying companies.
zacks.com
Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.
seekingalpha.com
Intuitive Surgical's da Vinci system is driving strong global growth, with 17% YoY procedure growth and expanding adoption across hospitals and specialties. Recurring revenue streams from system sales, procedures, and services support robust financials, including 21% YoY revenue growth and 68% gross margins. The company's expanding installed base and accelerating procedure growth position it for continued earnings stability and long-term shareholder returns.
zacks.com
Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.
zacks.com
Intuitive Surgical's Ion platform posted 52% procedure growth in Q2, but rising system utilization and workflow efficiency now drive its profitability focus.
zacks.com
Intuitive Surgical's Q2 gross margin declines to 67.9% as product mix shifts, new facility costs and tariffs weigh on profitability.
See all news
